close Video

NEW You can now listen to Fox News articles!

As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages.

The U.S. Food and Drug Administration has warned that so-called "gray-market" GLP-1s (such as semaglutide or tirzepatide) are not evaluated for safety, quality or efficacy.

As they fall outside the legal drug supply chain, these unapproved drugs may be counterfeit, contaminated or improperly compounded, the agency states.

WHY MICRODOSING OZEMPIC COULD BECOME AS COMMON AS TAKING A MULTIVITAMIN

Some are marketed online as "compounded semaglutide" or "research-use only," shipped directly to c

See Full Page